American Renal Associates Holdings, Inc. (NYSE: ARA) Investor Securities Class Action Lawsuit 03/28/2019

If you purchased a significant amount of shares of American Renal Associates Holdings, Inc. (NYSE: ARA) between August 10, 2016 and March 27, 2019, and / or if you purchased any NYSE: ARA shares prior to August 2016 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 27, 2019. NYSE: ARA investors should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
American Renal Associates Holdings
Case Name: 
American Renal Associates Holdings Shareholder Class Action Lawsuit 03/28/2019
Case Status: 
Lawsuit Filed
Affected Securities
NYSE: ARA
Lawsuit Overview
Type of Lawsuit: 
Shareholder Class Action
Date Filed: 
03/28/2019
Class Period Begin: 
08/10/2016
Class Period End: 
03/27/2019
Court of Filing: 
U.S. District Court for the District of New Jersey
Deadline To File for Lead: 
05/27/2019
Summary: 

An investor in shares of American Renal Associates Holdings, Inc. (NYSE: ARA) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by American Renal Associates Holdings, Inc. in connection with certain allegedly false and misleading statements made between August 10, 2016 and March 27, 2019.

According to the complaint the plaintiff alleges on behalf of purchasers of American Renal Associates Holdings, Inc. (NYSE: ARA) common shares between August 10, 2016 and March 27, 2019, that the defendants violated Federal Securities Laws.

Beverly, MA based American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States.

American Renal Associates Holdings, Inc. reported that its annual Total Revenue declined from $749.76 million in 2016 to $745.1 million in 2017 and that its Net Loss of $0.385 million in 2016 turned into a Net Income of $4.85 million in 2017.

Shares of American Renal Associates Holdings, Inc. (NYSE: ARA) reached $23.49 per share on October 1, 2018.

On March 8, 2019, American Renal Associates Holdings, Inc. announced it would delay the filing of its earnings report for the fiscal year ended December 31, 2018 as it continues to examine reserve computations and other accounting practices that may have an impact on the company’s accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years ranging from 2014 through 2017.

Shares of American Renal Associates Holdings, Inc. (NYSE: ARA) declined to $9.20 per share on March 11, 2019.